The Taizhou Medical High-tech Zone – also known as Gaogang district – is continuing to advance along the path to high-quality development, a process it has begun in recent years.
On March 9, a signing ceremony between Sysmex Shanghai Co Ltd and Jiangsu Zecen Biotech Co Ltd took place in Taizhou Medical High-tech Zone, also known as Gaogang district.
The Yangtze River Pharmaceutical Group was recently recognized as a national-level intelligent manufacturing pilot area in the traditional Chinese medicine sector.
On Feb 24, the third Healthy China Development Conference took place in Taizhou Medical High Tech Zone, with the theme being industrial cooperation and healthy China.
COVID-19 vaccine producer Jiangsu Recbio Technology Co Ltd broke ground on a vaccine expansion project with an investment of 1.08 billion yuan ($158.66 million) on Feb 6.
In the wake of the Spring Festival holiday, businesses resident in the Taizhou Medical High-tech Zone have restarted operations at a brisk pace, to ensure strong financial results in the first quarter.
